Background infusion of sufentanil in patient controlled intravenous analgesia pump (PCIA) after cesarean section: a randomized controlled trial

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000037940

Enrollment

Unknown

Registered

2020-09-04

Start date

2020-09-03

Completion date

Unknown

Last updated

2020-11-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patient-controlled intravenous analgesia of Postoperative

Interventions

Group A:Background dose was given

Group B:Background free dose

Eligibility

Sex/Gender

Female

Age

20 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. 60 parturients with single full-term pregnancy undergoing cesarean section from June 2020 to December 2020 in our hospital were selected, 2. Subjects aged 20-40 years, 37-42 weeks of gestation; 3. Subjects with height of 151-175cm and weight of 60-85kg; 4. Objects of ASA grade I or II; 5. All patients were connected with patient-controlled intravenous analgesia pump for postoperative analgesia.

Exclusion criteria

Exclusion criteria: 1. Patients with severe heart, lung, liver and kidney dysfunction; 2. Patients with gestational hypertension and fetal distress before operation; 3. Opioid tolerant patients and psychotic patients; 4. Patients with history of neurological diseases and opioid allergy.

Design outcomes

Secondary

Measure	Time frame
RAS Scale;PONV;	—

Primary

Measure	Time frame
NRS scale;	—

Countries

China

Contacts

Public ContactNie Zhongbiao

Shanxi Bethune Hospital

165361853@qq.com+86 13593164709

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026